Market Tracker

09/28 9:44am ET
81.34
BATS BZX Real-Time Price
As of 9:43am ET
 +0.46 / +0.57%
Today’s Change
69.90
Today|||52-Week Range
95.11
-5.46%
Year-to-Date
10 Stocks John Rogers Keeps Buying
Sep 27 / GuruFocus News - Paid Partner Content
Novartis Ilaris Approved for Extended Use in Periodic Fever
Sep 26 / Zacks.com - Paid Partner Content
Kite Pharma Reports Favorable Data from Lymphoma Study
Sep 27 / Zacks.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Why Kite Pharma's Stock Is Soaring Today
Sep 27 / MotleyFool.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
Sep 26 / TheStreet.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.88
Today’s open81.21
Day’s range81.21 - 81.34
Volume20,356
Average volume (3 months)1,512,495
Market cap$188.0B
Dividend yield3.34%
Data as of 9:43am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-4.75%
P/E ratio29.2
Price/Sales4.25
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.68+1.09%
PFEPfizer+0.02+0.06%
GSKGlaxoSmithKline+0.36+0.83%
ABBVAbbVie-0.12-0.19%
Data as of 9:44am ET, 09/28/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$1.19
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts